COMMUNIQUÉS West-GlobeNewswire
-
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
08/04/2026 -
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
08/04/2026 -
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
08/04/2026 -
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026 -
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
08/04/2026 -
Medline to report first quarter 2026 results on May 6, 2026
08/04/2026 -
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
08/04/2026 -
Aeroflow Health Celebrates Wisconsin’s Extension of Postpartum Care
08/04/2026 -
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
08/04/2026 -
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference
08/04/2026 -
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026 -
SafeSpace Global Corporation to Present at the Centri Capital Conference at Nasdaq MarketSite
08/04/2026 -
American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
08/04/2026 -
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
08/04/2026 -
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
08/04/2026 -
Life Biosciences Secures $80 Million Series D Financing
08/04/2026 -
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
08/04/2026 -
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
08/04/2026 -
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
08/04/2026
Pages